Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals.

@article{Adamis2006ChangesIR,
  title={Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals.},
  author={Anthony P. Adamis and Michael M. Altaweel and Neil M. Bressler and Emmett T. Cunningham and Matthew D. Davis and Mauro Goldbaum and Christine Gonzales and David R. Guyer and Katz Barrett and Manju Patel},
  journal={Ophthalmology},
  year={2006},
  volume={113 1},
  pages={
          23-8
        }
}
OBJECTIVE To study effects of intravitreal pegaptanib (Macugen) on retinal neovascularization. DESIGN Retrospective analysis of a randomized clinical trial. PARTICIPANTS, INTERVENTION, AND MAIN OUTCOME MEASURES: Individuals with retinal neovascularization identified from a multicenter, randomized, controlled trial evaluating pegaptanib for treatment of diabetic macular edema, with a best-corrected visual acuity letter score between 68 and 25 (approximate Snellen equivalent between 20/50 and… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 91 CITATIONS

Similar Papers

Loading similar papers…